Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial‐mesenchymal transition and stemness by regulating the miR ‐515‐5p/ AKT2 axis and PI3K / AKT / mTOR signaling pathway
Authors:
- 19 July 2023
- journal article
- research article
- Published by Wiley in Environmental Toxicology
- Vol. 38 (11) , 2632-2644
Abstract
Biliary tract cancer (BTC) is a devastating malignancy that is notoriously difficult to diagnose and is associated with high mortality. Circular RNA (circRNA) is a class of endogenous non‐coding RNA which has been regarded as the key regulator of tumor initiation and progression, including BTC. Circular RNA nuclear receptor interacting protein 1 (circ_NRIP1), as a circular RNA, is abnormally expressed in many human tumors and exhibits diverse functions in cancer progression. However, its biological significance in BTC has not been thoroughly investigated. In this research, we elucidated that circ_NRIP1 was notably overexpressed in both BTC tissues and cells. We further established a correlation between circ_NRIP1 expression and clinicopathological features in BTC patients, highlighting its clinical relevance. Through functional assays, we observed that knockdown of circ_NRIP1 significantly inhibited tumor cell proliferation, invasion, stemness maintenance, and epithelial‐mesenchymal transition, indicating its active involvement in promoting BTC progression. Additionally, it attenuated growth of xenograft and metastasis models. Mechanically, we revealed that circ_NRIP1 served as the competing endogenous RNA to sequester miR‐515‐5p through complementary base pairing mechanism, thereby upregulated AKT2 expression and indirectly activated PI3K/AKT/mTOR signaling pathway. Generally, targeting the circ_NRIP1/miR‐515‐5p/AKT2 axis and aberrant activation of the PI3K/AKT/mTOR pathway may hold promising therapeutic strategies for BTC. Our research contributes to a better understanding of the underlying biological basis of BTC and paves the way for the development of innovative treatment approaches.Keywords
Funding Information
- Heilongjiang Provincial Postdoctoral Science Foundation (LBH‐Q21023)
This publication has 42 references indexed in Scilit:
- Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathwayBioscience Reports, 2019
- Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathwayMolecular Cancer, 2019
- Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes MellitusCirculation, 2017
- Cholangiocarcinoma — evolving concepts and therapeutic strategiesNature Reviews Clinical Oncology, 2017
- Cancer stem cells revisitedNature Medicine, 2017
- Emerging molecular therapeutic targets for cholangiocarcinomaJournal of Hepatology, 2017
- A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-β1Biochemical and Biophysical Research Communications, 2017
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancerMolecular Cancer, 2017
- Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)Nature Reviews Gastroenterology & Hepatology, 2016
- Cholangiocarcinoma—controversies and challengesNature Reviews Gastroenterology & Hepatology, 2011